Stereotaxis (STXS) Total Current Liabilities (2010 - 2026)
Stereotaxis (STXS) posted quarterly Total Current Liabilities of $23.1 million for Q1 2026, down 4.72% year-over-year from $24.2 million in Q1 2025, and up 3.25% quarter-over-quarter from $22.4 million in Q4 2025.
Stereotaxis (STXS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Total Current Liabilities for 17 consecutive years, with $23.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 4.72% year-over-year to $23.1 million; the TTM figure through Mar 2026 stood at $23.1 million (down 4.72% YoY), while the FY2025 annual figure was $22.4 million, up 3.51% from the prior year.
- Total Current Liabilities grew to $23.1 million in Q1 2026 per STXS's latest filing, from $22.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $24.2 million in Q1 2025 and bottomed at $11.5 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $16.9 million across 5 years, with a median of $14.4 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities sank 31.14% — and 2025, when it jumped 88.52%.
- Stereotaxis' Total Current Liabilities stood at $14.3 million in 2022, then slipped by 7.31% to $13.2 million in 2023, then surged by 63.07% to $21.6 million in 2024, then climbed by 3.51% to $22.4 million in 2025, then rose by 3.25% to $23.1 million in 2026.
- Business Quant data shows STXS's Total Current Liabilities at $23.1 million in Q1 2026, $22.4 million in Q4 2025, and $20.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 23.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.09 Mn |
| Dec 31, 2025 | 22.36 Mn |
| Sep 30, 2025 | 20.37 Mn |
| Jun 30, 2025 | 20.75 Mn |
| Mar 31, 2025 | 24.23 Mn |
| Dec 31, 2024 | 21.60 Mn |
| Sep 30, 2024 | 20.72 Mn |
| Jun 30, 2024 | 12.25 Mn |
| Mar 31, 2024 | 12.85 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 13.03 Mn |
| Jun 30, 2023 | 14.38 Mn |
| Mar 31, 2023 | 14.27 Mn |
| Dec 31, 2022 | 14.29 Mn |
| Sep 30, 2022 | 15.55 Mn |
| Jun 30, 2022 | 13.66 Mn |
| Mar 31, 2022 | 11.49 Mn |
| Dec 31, 2021 | 13.26 Mn |
| Sep 30, 2021 | 13.84 Mn |
| Jun 30, 2021 | 13.44 Mn |